Prospective study of circulating angiogenic markers in prostate-specific antigen (PSA)-stable and PSA-progressive hormone-sensitive advanced prostate cancer

By Kohli M.   Kaushal V.   Spencer H.J.   Mehta P.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 765-769

Elsevier

Access to resources Recommend Favorite

Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized disease

By Zietman A.L.   Dallow K.C.   McManus P.A.   Heney N.M.   Shipley W.U.  

Urology, Vol. 47, Iss. 2, 1996-02 ,pp. : 236-239

Elsevier

Access to resources Recommend Favorite

Impact of prostate-specific antigen screening on prostate cancer

By Zincke H.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 783-783

Elsevier

Access to resources Recommend Favorite

Clear cell adenocarcinoma of the female urethra showing positive staining with antibodies to prostate-specific antigen and prostatic acid phosphatase

By Ebisuno S.   Miyai M.   Nagareda T.  

Urology, Vol. 45, Iss. 4, 1995-04 ,pp. : 682-685

Elsevier

Access to resources Recommend Favorite

Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer

By Pannek J.   Rittenhouse H.G.   Evans C.L.   Finlay J.A.   Bruzek D.J.   Cox J.L.   Chan D.W.   Subong E.N.P.   Partin A.W.  

Urology, Vol. 50, Iss. 5, 1997-11 ,pp. : 715-721

Elsevier

Access to resources Recommend Favorite